Bergen, Norway, March 24, 2025 – On March 11, at the Frisk Fisk conference in Tromsø, Norway, Vaxxinova presented advances in the development of a vaccine against Tenacibaculum finnmarkense. The presentation, given by Vaxxinova BU Aqua Diagnostics Manager Helge-Andre Erikstad, highlighted promising results from vaccine prototypes against this bacterium, including high levels of protection under […]
Nijmegen, The Netherlands, March 24, 2025 – On Friday, March 14th, a large delegation of Vaxxinova employees participated in a rewarding volunteer day. Our team spent the day nursing home De Linge in Bemmel, engaging in various activities to bring joy and support to the residents. From playing games and taking walks with the residents […]
Nijmegen, The Netherlands, February 14, 2025 – VIV Asia, the biggest tradeshow of its kind in Asia, is back in Bangkok, Thailand from March 12-14. VIV Asia is dedicated to the world of livestock production, animal husbandry and all related sectors. Of course animal health solutions are in focus, and Vaxxinova is there! Vaxxinova’s team […]
Nijmegen, The Netherlands, January 20, 2025 – Vaxxinova is pleased to announce the appointment of Dr Exequiel F. Brobio (Kai) as Country Representative for Philippines. As of January 20, Dr Exequiel is part of the Vaxxinova team in the Asia-Pacific region. In his role as Country Representative, he will support Vaxxinova partners and customers in […]
Willmar, MN, USA – January 14, 2025. From January 28-30, 2025 the International Production & Processing Expo, the world’s largest annual poultry and egg, meat and animal food industry event of its kind, takes place. As usual Atlanta, GA, USA is the city where it all happens. Vaxxinova will be exhibiting in Hall B – […]
Nijmegen, NL, January 14 2025 – From December 2024 to February 2025 Vaxxinova’s team in the International Zone (APAC, MENA and SSA) is on the road in a serie of roadshows in 4 different countries. ‘Vaxxiknowledge – Sharing Solutions, Advancing Poultry Health’ is the title of the seminars, where Vaxxinova and external experts share knowledge […]
Nijmegen, the Netherlands, Jan 7, 2025 – We are pleased to announce that, as per Monday January 6, 2025, Kristi Moore joins Vaxxinova as Chief Scientific Officer. Kristi (USA) brings over 30 years of R&D experience and 26 years of industry experience in animal health research with expertise in poultry vaccines. Kristi has a proven […]
Willmar, Minnesota, Dec 23, 2024 — Vaxxinova US proudly announces a groundbreaking development for animal health and the poultry industry. The United States Department of Agriculture (USDA) has approved importation of a live Avian metapneumovirus vaccine, Vaxxon® SHS, into the U.S. market. This unprecedented approval marks a significant milestone in the fight against Avian metapneumovirus […]
Nijmegen, NL / Brescia, IT, November 28, 2024 – Today Vaxxinova® is pleased to announce that the European Commission has granted a marketing authorization for the poultry vaccine 𝗩𝗮𝘅𝘅𝗼𝗻® 𝗡𝗗 𝗖𝗹𝗼𝗻𝗲 in the EU. The adoption follows the positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency […]
Sao Paulo, November 2024 – Vaxxinova Brasil has approved its new vaccine facility in lbiuna, Sao Paulo, dedicated to the production of live vaccines against avian coccidiosis. With 4,000 m2 of constructed area and an annual production capacity of more than five times the current one, the project, which began in 2020 and was completed […]